» Articles » PMID: 16536739

Amyloid Precursor Protein and Notch Intracellular Domains Are Generated After Transport of Their Precursors to the Cell Surface

Overview
Journal Traffic
Publisher Wiley
Specialties Biology
Physiology
Date 2006 Mar 16
PMID 16536739
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is characterized by brain deposition of extracellular amyloid beta-peptide (Abeta)-containing plaques. The cellular site of gamma-secretase activity, which releases Abeta and the corresponding amyloid precursor protein intracellular domain (AICD), remains controversial. Proposed cleavage sites range from the endoplasmic reticulum (ER), the Golgi apparatus, and the cell surface to endosomal compartments. We now used C99-green fluorescent protein (GFP), a fluorescent reporter substrate for gamma-secretase activity and monitored AICD production in living cells. C99-GFP is efficiently cleaved by gamma-secretase, and AICD-GFP is released into the cytosol. Inhibiting gamma-secretase results in accumulation of C99-GFP in early endosomes. By blocking selective transport steps along the secretory pathway, we demonstrate that gamma-secretase does not cleave its substrates in the ER, the Golgi/trans-Golgi network, or in secretory vesicles. In contrast, inhibition of endocytosis did not inhibit cleavage of C99-GFP. Similar results were obtained for another gamma-secretase substrate, NotchDeltaE. Our results suggest that intracellular domains are generated by gamma-secretase at the plasma membrane and/or early endosomes.

Citing Articles

The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer's Disease Mouse Model.

Latina V, Atlante A, Malerba F, La Regina F, Balzamino B, Micera A Int J Mol Sci. 2023; 24(11).

PMID: 37298634 PMC: 10253571. DOI: 10.3390/ijms24119683.


Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease.

Kabir E, Chowdhury N, Yasmin H, Kabir M, Akter R, Perveen A Curr Neuropharmacol. 2022; 21(4):787-807.

PMID: 36221865 PMC: 10227919. DOI: 10.2174/1570159X20666221010113812.


Amylin and Secretases in the Pathology and Treatment of Alzheimer's Disease.

Singh S, Yang F, Sivils A, Cegielski V, Chu X Biomolecules. 2022; 12(7).

PMID: 35883551 PMC: 9312829. DOI: 10.3390/biom12070996.


Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.

Cannavo C, Cleverley K, Maduro C, Mumford P, Moulding D, Fisher E PLoS One. 2022; 17(5):e0262558.

PMID: 35544526 PMC: 9094519. DOI: 10.1371/journal.pone.0262558.


Enhanced cleavage of APP by co-expressed Bace1 alters the distribution of APP and its fragments in neuronal and non-neuronal cells.

Aow J, Huang T, Thinakaran G, Koo E Mol Neurobiol. 2022; 59(5):3073-3090.

PMID: 35266114 DOI: 10.1007/s12035-022-02733-6.